APA (7th ed.) Citation

W, I., M, A., S, Z., D, G., C, J., Q, Q., . . . T, Z. (2026). Real-World Treatment Outcomes in Patients With Ga68-PSMA-PET Positive Metastatic Hormone-Sensitive Prostate Cancer With or Without Conventional Imaging Correlates. Clinical genitourinary cancer, 24(1), 102476. https://doi.org/10.1016/j.clgc.2025.102476

Chicago Style (17th ed.) Citation

W, Issa, et al. "Real-World Treatment Outcomes in Patients With Ga68-PSMA-PET Positive Metastatic Hormone-Sensitive Prostate Cancer With or Without Conventional Imaging Correlates." Clinical Genitourinary Cancer 24, no. 1 (2026): 102476. https://doi.org/10.1016/j.clgc.2025.102476.

MLA (9th ed.) Citation

W, Issa, et al. "Real-World Treatment Outcomes in Patients With Ga68-PSMA-PET Positive Metastatic Hormone-Sensitive Prostate Cancer With or Without Conventional Imaging Correlates." Clinical Genitourinary Cancer, vol. 24, no. 1, 2026, p. 102476, https://doi.org/10.1016/j.clgc.2025.102476.